More than 96 percent of people develop coronavirus antibodies within 28-34 days of receiving the first dose of the AstraZeneca or Pfizer vaccine, new research that sampled more than 8000 participants, has revealed.
The England- and Wales-based study also found that almost 100 percent of people develop immune cells to successfully fight off coronavirus after receiving two shots.
Researchers found that 96.42 percent of people who received the AstraZeneca or Pfizer vaccine developed antibodies 28-34 days after a first dose.
RELATED STORY: Parents urged to get their kids vaccinated following MOHAP’s approval of Pfizer’s COVID-19 jab for teens
The figure grew to 99.08 percent within seven to 14 days of receiving a second jab, according to British newspapers.
“This is one of the earliest real-world vaccine studies in the UK and it is fantastic news,” said Dr. Maddie Shrotri, lead author of the research paper.
“More than nine out of 10 adults in the UK who had either the Pfizer or AstraZeneca vaccine produced antibodies against the virus within a month of their first shot,” she added.
“How well these vaccines work is remarkable, especially given the speed at which they’ve been developed. It’s a real feat of science in the face of the most devastating pandemic in a century.”
The study, conducted by University College London (UCL) scientists, could have positive implications on the worldwide fight against the coronavirus pandemic. It will be placed through a peer review process before submission to a medical journal.
READ ON: US to boost vaccine sharing commitment to 80 million doses
UCL scientists found that both vaccines were equally capable of triggering the antibody response that can ward off severe coronavirus infections.
However, antibody levels after a single jab were discovered to be lower in older people and those with underlying health conditions, including cancer, diabetes and heart disease. A second vaccine dose fixed that in this group.
The study is a “timely reminder” about the importance of receiving a second dose, said Prof. Rob Aldridge, chief investigator of the UCL study. “But it is also reassuring — vaccines will take us out of the pandemic.” (AW)
